HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
Opthalamic Drug Delivery Systems
Ophthalmic drug delivery systems encompass a range of specialized methods and technologies designed for the targeted administration of medications to the eyes. These systems play a crucial role in treating various ocular conditions by enhancing drug efficacy, improving patient compliance, and minimizing side effects.
Intraocular Injections:
Intravitreal Injections: Direct injections into the vitreous cavity of the eye, commonly used for treating conditions such as macular degeneration or diabetic retinopathy. Implantable Devices:
- Ocular Inserts: Solid devices placed in the conjunctival sac that release drugs gradually over an extended period, providing a sustained therapeutic effect.
- Drug-Eluting Contact Lenses: Contact lenses designed with materials that release drugs onto the ocular surface for controlled and prolonged drug delivery.
Challenges and Innovations:
- Tear Turnover: Addressing the dynamic nature of tear turnover is a challenge for ensuring prolonged drug retention in the eye.
- Corneal Barrier: Overcoming the corneal barrier is a focus for developing strategies that facilitate effective drug penetration into intraocular tissues.
Committee Members
Yong Xiao Wang
Albany Medical College, United States
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States PDDS 2025 Speakers
Bernd Blobel
University of Regensburg, Germany
Huiqin Yang
ICON Clinical Research Ltd, United Kingdom
Srividya Narayanan
Northeastern University, United States
Maria Richards Brown
University College London, United Kingdom
Rassa Pegahi
UPSA, France
Hanieh Khalili
University of East London, United KingdomSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico